Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


29.01.2018

1 Ann Rheum Dis
1 BMJ
4 Clin Exp Rheumatol
4 Clin Rheumatol
2 Curr Opin Rheumatol
1 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. VAN HOOVELS L, Jacobs J, Vander Cruyssen B, Van den Bremt S, et al
    Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jan 23. pii: annrheumdis-2017-212365.
    PubMed     Text format     Abstract available


    BMJ

  2. MAYOR S
    Test patients with rheumatoid arthritis for anti-CCP antibodies, says NICE.
    BMJ. 2018;360:k299.
    PubMed     Text format    


    Clin Exp Rheumatol

  3. BO M, Erre GL, Niegowska M, Piras M, et al
    Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 11919.
    PubMed     Text format     Abstract available

  4. IANNAZZO S, Benucci M, Favalli EG
    Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12043.
    PubMed     Text format     Abstract available

  5. FERRAZ-AMARO I, Lopez-Mejias R, Tejera-Segura B, de Vera-Gonzalez AM, et al
    Amylin in the insulin resistance of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12060.
    PubMed     Text format     Abstract available

  6. LEI X, Li H, Zhan Y, Qu J, et al
    Predict rheumatoid arthritis conversion from undifferentiated arthritis with dynamic contrast-enhanced MRI and laboratory indexes.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12185.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  7. STRAUB RH, Ehrenstein B, Gunther F, Rauch L, et al
    Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.
    Clin Rheumatol. 2017;36:1041-1051.
    PubMed     Text format     Abstract available

  8. KIADALIRI AA, Englund M
    Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.
    Clin Rheumatol. 2018 Jan 22. pii: 10.1007/s10067-018-3983.
    PubMed     Text format     Abstract available

  9. ROMANO C, Del Mastro A, Sellitto A, Solaro E, et al
    Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.
    Clin Rheumatol. 2018 Jan 23. pii: 10.1007/s10067-018-3992.
    PubMed     Text format     Abstract available

  10. PETERSEN LE, Baptista TSA, Molina JK, Motta JG, et al
    Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors.
    Clin Rheumatol. 2018 Jan 25. pii: 10.1007/s10067-018-3990.
    PubMed     Text format     Abstract available


    Curr Opin Rheumatol

  11. DIXON WG, Michaud K
    Using technology to support clinical care and research in rheumatoid arthritis.
    Curr Opin Rheumatol. 2018 Jan 23. doi: 10.1097/BOR.0000000000000485.
    PubMed     Text format     Abstract available

  12. BERGSTRA SA, Allaart CF
    What is the optimal target for treat-to-target strategies in rheumatoid arthritis?
    Curr Opin Rheumatol. 2018 Jan 19. doi: 10.1097/BOR.0000000000000484.
    PubMed     Text format     Abstract available


    Rheumatol Int

  13. LOPEZ-LONGO FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F, et al
    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    Rheumatol Int. 2018 Jan 24. pii: 10.1007/s00296-018-3933.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: